New Delhi, Oct 1 (PTI) Researchers at Indian Institute of Technology (IIT) Delhi have developed a catalytic technology for the sustainable and economical synthesis of chiral molecules which are essential building blocks to produce pharmaceuticals, agrochemicals and biologically active compounds.

According to the research team, India is heavily dependent on importing (above 85 per cent) Active Pharmaceutical Ingredients (APIs), and a significant proportion of those APIs are chiral molecules.

Also Read | Chennai Super Kings Favourites To Win IPL 2021: Here Are Three Reasons Why MS Dhoni-led CSK Would Win Fourth Indian Premier League Title This Year.

"The developed catalytic technology may play a crucial role in decreasing the country's dependence on the import of the Active Pharmaceutical Ingredients, which also means lowering of the input cost for the industry that would encourage it to pass on the benefit to the society," said Kuntal Manna, Professor at IIT Delhi's Chemistry department.

He said the existing methodologies "are costly and not eco-friendly".

Also Read | Amazon Great Indian Festival Sale 2021: Apple iPhone 11 Price To Drop Below Rs 40,000.

"To tackle this problem, the research team developed a Metal-Organic Framework-based catalytic technology using inexpensive natural feedstocks and abundant metals for the sustainable and economical synthesis of enantiomerically pure chiral molecules," Manna said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)